Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 218.24B |
| Revenue (ttm) | 42.86B |
| Net Income (ttm) | 6.00B |
| Shares Out | 381.71M |
| EPS (ttm) | 15.45 |
| PE Ratio | 37.01 |
| Forward PE | 26.30 |
| Dividend | $1.56 (0.27%) |
| Ex-Dividend Date | Mar 14, 2024 |
| Volume | 1,183,730 |
| Open | 577.40 |
| Previous Close | 577.39 |
| Day's Range | 569.98 - 577.99 |
| 52-Week Range | 415.60 - 603.82 |
| Beta | 0.80 |
| Analysts | Buy |
| Price Target | 607.50 (+6.26%) |
| Earnings Date | Apr 24, 2024 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno... [Read more]
Financial Performance
In 2023, TMO's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for TMO stock is "Buy." The 12-month stock price forecast is $607.5, which is an increase of 6.26% from the latest price.
News
Thermo Fisher lifts profit forecast as medical equipment demand improves
Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and services used in drug development and ...
Thermo Fisher Scientific to Host Investor Day
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) i...
Thermo Fisher Scientific Reports First Quarter 2024 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First ...
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel ani...
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets
MUNICH--(BUSINESS WIRE)--Analytica 2024 - Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for cust...
Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times
CARLSBAD, Calif.--(BUSINESS WIRE)--Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low te...
Final Trades: GXO Logistics, Thermo Fisher & Nasdaq
The Investment Committee gives you their top stocks to watch for the second half.
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2024 before ...
Thermo Fisher Scientific Announces a New In-line Metrology Solution to Improve Battery Safety and Performance
WALTHAM, Mass.--(BUSINESS WIRE)--To address the needs of the rapidly growing battery market, Thermo Fisher Scientific today introduced the Thermo Scientific™ LInspector™ Edge In-line Mass Profilometer...
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
BERLIN & CARLSBAD, Calif.--(BUSINESS WIRE)--Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CD...
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
BERLIN & CARLSBAD, Calif.--(BUSINESS WIRE)--Bayer AG and Thermo Fisher Scientific Inc. today announced to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. The...
Calls of the Day: Regeneron, Thermo Fisher, Darden Restaurants and Nucor
The Investment Committee debate the latest calls of the day on a number of stocks.
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalized Pustular Psoriasis
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today announced the launch of a new CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP).
Trade Tracker: Jim Lebenthal sells Thermo Fisher
Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to explain why he sold Thermo Fisher.
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the...
Final Trades: Thermo Fisher, Samsara and IYR
Today's ‘Halftime Report' Investment Committee, Karen Firestone, Shannon Saccocia and Josh Brown give their top picks to watch for the second half.
Medidata and Thermo Fisher Scientific's PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewed its relationship with th...
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Thermo Fisher Scientific Increases Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees
CARLSBAD, Calif.--(BUSINESS WIRE)--Today, Thermo Fisher Scientific announced the latest recipients of the Oncomine Clinical Research Grant, recognizing research from the Melanoma Institute Australia, ...
Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership
WALTHAM, Mass.--(BUSINESS WIRE)--For the 11th consecutive year, Thermo Fisher Scientific's pharma and biopharma customers recognized its contract manufacturing excellence through the annual CDMO Leade...
Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
WALTHAM, Mass.--(BUSINESS WIRE)--To support a wider range of ion chromatography analysis with one instrument, Thermo Fisher Scientific Inc., today launched the Thermo Scientific™ Dionex™ Inuvion™ Ion ...
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing
WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific's PPD clinical research business adding mycoplasma and additional biosafety testing capabilities at Wisconsin GMP lab.
Multiply Labs and Thermo Fisher Scientific Expand Partnership to Automate Cell Expansion and Separation in Cell Therapy Manufacturing
SAN FRANCISCO--(BUSINESS WIRE)-- #manufacturing--Automating Thermo Fisher's instruments using Multiply Labs' robotic tech helps reduce costs and accelerates timelines for cell therapy manufacturing.